Rina Kato

Dienogest compared with gonadotropin‐releasing hormone agonist after conservative surgery for endometriosis

Yotaro Takaesu, Hirotaka Nishi, Junya Kojima et al. · Journal of obstetrics and gynaecology research · 2016 · 81 citations

Medicine, Gynecology, Pharmacotherapy +13

Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor

Kiyoshi Hasegawa, Yoshimasa Ohashi, K Ishikawa et al. · International Journal of Oncology · 2005 · 48 citations

Medicine, Oncology, Pharmacology +8

Effects of a selective COX-2 inhibitor in patients with uterine endometrial cancers

Kiyoshi Hasegawa, Y. Torii, Risa Ishii et al. · Archives of Gynecology and Obstetrics · 2011 · 20 citations

Medicine, Oncology, Pharmacology +6

The Relationship Between ERCC1 Expression and Clinical Outcome in Patients With FIGO Stage I to Stage II Uterine Cervical Adenocarcinoma

Kiyoshi Hasegawa, Rina Kato, Y. Torii et al. · International Journal of Gynecological Cancer · 2011 · 19 citations

Medicine, Oncology, Pathology +17

ERCC1 expression and chemosensitivity in uterine cervical adenocarcinoma cells.

Y. Torii, Rina Kato, Yukito Minami et al. · PubMed · 2014 · 18 citations

Medicine, Oncology, Pharmacology +13